Pod Insights Pharmacy Podcast Network Pharmacy Forward: DSCSA Readiness with PrimeRx and InfiniTrak | PrimeRx About this episode The Drug Supply Chain Security Act (DSCSA) is a U. S. law aimed at ensuring the integrity and safety of the pharmaceutical supply chain. Enacted as part of the Drug Quality and Security Act in 2013, DSCSA establishes national standards for tracking and tracing prescription medications as they move from manufacturers through wholesalers, distributors, and eventually to pharmacies and patients. Here’s a breakdown of the key requirements: Product Tracking: DSCSA mandates that all prescription drugs have a standardized, unique identifier (often a 2D barcode) on their packaging. This makes it easier to track medications at each point in the supply chain. Verification: Each trading partner (manufacturer, wholesaler, dispenser, etc.) must verify that products are legitimate and free from counterfeits before they are distributed. Enhanced Security: By November 2024, pharmacies and other stakeholders must implement "interoperable" systems for tracking products electronically. This step involves using systems that can communicate seamlessly across the industry. Documentation: Trading partners need to maintain detailed records of the products they handle and their movements. This helps track and trace drugs if a safety issue or recall occurs. Overall, DSCSA aims to protect patients by reducing the chances of counterfeit, stolen, or contaminated drugs entering the U. S. supply chain, making it safer and more transparent. Visit Us at PrimeRx.io
Transcript 0:05 Speaker 00 You are listening to the global network of podcasters dedicated to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
0:28 Speaker 01 We are committed to the pharmacy owner's success. PrimeRx believes in empowering pharmacies with innovative solutions to thrive in today's competitive landscape. We look forward to working with pharmacy owners and sharing how our solutions can contribute to their sustained profitability and growth. Connect with us on the web by going to primerx.io. That's primerx.io.
0:51 Speaker 02 Hey, welcome back to PrimeRx. This is a podcast series that we have been excited to partner with the PrimeRx team. I look to that organization, a shout out to Larry Stevenson. Just everything that this organization has done for the industry, for our independent community pharmacies. We see them at conferences, we see the investments that they've made. Their website, if you don't have an update, primerx.io. Once again, that's primerx.io. Today, what an exciting time in the profession of pharmacy. Payment is changing, pharmacies' roles are changing.
1:35 Speaker 02 We have collaborative agreements that are increasing. The consultant role of our pharmacist will continue to grow. When you talk about that, we have to talk about technology that supports our clinical pharmacist, our clinician pharmacists, the independent community pharmacies. And part of that is making sure that we're compliant and that we are mitigating the risk of our independent community pharmacies. Once again, that's an investment that PrimeRx makes into the core of their partnerships and of their system. We're going to be talking about pharmacy forward, the DSCSA readiness with Primer X and
2:16 Speaker 02 InfiniTrak and really understanding where are we with the Drug Supply Chain Security Act, the DSCSA and what that means for our industry. And we bring experts to these panels. I'm certainly not the expert. I, that's why we have these podcasts to gather the people that know what they're talking about. I would like to introduce the Vice President of Data Analytics and Partnerships with Primer X, Sam Pizzo. It is so good to see you.
2:45 Speaker 03 Hey Todd, good to see you too. And thank you for, for putting this together. Excited to be here. It's been a very busy year. I'm actually going into my sixth month here at Primer X. And I'm just excited to be part of the team as we, as we move forward. I've actually been working with Mark Tate and InfiniTrak for, for a couple of years now, helping them put together their processes and procedures as well. And then came over here at Primer X to, to help in other aspects of the industry. Just coming off of NCPA in Columbus this past week. Really
3:25 Speaker 03 good to see pharmacies out there, learning, looking at new technology, looking at what needs to be done, what they need to be doing, talking to other people, just kind of a, still on a little high from, from that, from being there. So now getting home, getting back home and just trying to get back into moving forward and getting some things done.
3:47 Speaker 02 I agree. The month has gone by so quickly. Three conferences this month for the Pharmacy Podcast Network, and I haven't decompressed yet to the energy and the hope that was part of the NCPA. And in the clarity, lots of information, lots of discussions and the compliance part in the stop, the start, the shift around DSCSA was one of my many conversations that were there. And I didn't have you with me, Sam. So would have liked to actually had our, our guest today, the star of our show today is Mark Tate. He's President of InfiniTrak. Mark, welcome to the show.
4:29 Speaker 04 Thanks, thanks a lot. It's great to be on the podcast here. It's not our first time. We've been doing compliance with Drug Supply Chain Security Act way back since 2016. And we've participated in your podcasts that are always incredibly valuable and beneficial. And it's really an honor to be here. And it's great to be on with Sam. As Sam referenced, he's worked with us at InfiniTrak in the past and helped us understand pharmacies to make a great product for dispensers to make sure that we were able to work well and help solve issues. And so it's a real honor to be on with Sam, who's a good friend.
5:13 Speaker 04 I was also just at NCPA and we were very excited to see the real intense focus on Drug Supply Chain Security Act and the need to get compliance. As you said, it's been a kind of a roller coaster ride with Drug Supply Chain Security Act when it launched in 16 and it delayed and started and people focused on it. People didn't focus on it. Now we're at the real deadline and people are really focused. We had enormous amount of conversations and being a lot of new customers there at NCPA.
5:51 Speaker 04 And we were excited to be there. But I'm very excited to be on this podcast to talk about where we are. Talk about some of these exemptions, talk about what needs to be done for a dispenser as we approach the November 27 deadline.
6:10 Speaker 02 November 27 deadline that really stands out to me, Mark, just on who talks with pharmacy owners weekly in different sectors, long-term care, specialty, community pharmacy. We have to kind of make the definition first, just in case we have some listeners that are refreshed, need refreshed, or don't understand DSCSA. This is a law aimed at ensuring the integrity and safety of the pharmaceutical supply chain. Give us an overall definition, Mark, as to the DSCSA.
6:47 Speaker 04 Sure, I'd love to do that. So it's really about patient safety. It really is. It's a law that allows us to work as a community within the supply chain to track drug transactions from the manufacturer all the way to the dispenser, the purpose being to prevent counterfeits and tampered with drugs or harmful drugs from getting to patients. It's been a long process. We work collaboratively with a lot of other vendors, third-party vendors, wholesalers, manufacturers, third-party logistics partners, to be able to track all of this data, ensure the veracity of the product as it gets to the patient.
7:29 Speaker 04 It's been a little bit of a lift to be able to do it. Fundamentally, what you need to be able to do is track all of what we call T3, or now we call it T2 data, the transaction data of all the drugs that are shipped from the manufacturer to the wholesaler, to the dispenser. Save that data for at least six years. You need to be verifying your authorized trading partners to make sure they're fully licensed, so you're not doing business with bad actors within the supply chain. You need to be able to identify what we call suspect product or illegitimate product, identify and document it, report it to the FDA and to the trading partners and boards of pharmacies,
8:13 Speaker 04 so we can get a hold of whether there's bad product out there, whether it's harmful product out there. And then, now we're moving into the second phase where we're doing interoperable functions, receiving serialized data, so we can track down to the specific product. We can figure out where problems are happening in the supply chain. We can prevent counterfeits being out there. Often, when you're talking to pharmacists, they believe they don't have any or very much suspect product. But the reality is, there's a lot of counterfeit out there. The biggest... Latest example is counterfeit Ozempic.
8:58 Speaker 04 Counterfeit happening about a month and a half ago, where a bad actor stole a serial number, reproduced the serial number of the product in the in a product identifier in the data, reproduced it tens of thousands of times, he got that product into the market. He tried to sell it to patients. It was basically, it was a counterfeit that they produced. And it was pharmacists that were able to uncover that counterfeit, partially through the structure of the supply of the drug supply chain to curiate, ultimately protecting patients. Again, there was another counterfeit earlier on HIV drugs,
9:41 Speaker 04 which were tremendously dangerous. But they were able to slip that into the supply chain. And it was discovered when patients were not getting the benefit from the drug that they were supposed to be. And again, a pharmacist was able to uncover that and report that, get an investigation, find the source and get it out of the market. So it's, you know, it's a very important, very important regulation for patient safety. And I'm a little bit of a geek on compliance, but I'm very excited to be involved in this, to be able to help protect patients, protect healthcare, to make sure that they're getting good drugs.
10:23 Speaker 02 Yeah, we are, we are protecting the patients. We're reducing the chances of counterfeit, tracking and finding the stolen
10:32 Speaker 02 components, the compounds, the medications, contaminated drugs entering the US supply chain is a major issue. And you're in this system, the complacency is going to make it safer and obviously more transparent. That, that one, that's time to actually shift the gear. Sam, back to you. And that is, why don't you give us your insights on how DSCSA compliance will affect pharmacies? And what has become the prime or X major push is to ensure this. And what you're doing to be as compliant as possible and making this less painful for our pharmacy owners?
11:11 Speaker 03 Sure, sure. As I mentioned earlier, I have worked with InfiniTrak for the last couple of years with Mark, the team and whatnot, knowing that the full implementation of DSCSA is going to affect the pharmacies where additional work is going to need to be done. So what we've done at PrimeRx, having a clear understanding of the workflow within pharmacies and what needs to be done, it's important for pharmacies to understand what they need to be doing. As an example, the scanning part. So the pieces that Mark just put together and outlined about saving data, having an
11:56 Speaker 03 SOW, quarantining or looking for suspect products, that's in place today. The mandate for those pieces are already in place. Pharmacies are supposed to be doing that. Come November, now 27th, a little less than a month, they're going to be responsible for all the pieces. And Mark can get into the, there's a couple of exceptions still left. So this law has been a little complicated, convoluted, like you mentioned at the beginning of the discussion here. But what we did at PrimeRx, and I think is really one of the best ways to help pharmacies,
12:37 Speaker 03 you've got to remember, the key thing in order to be compliant, InfiniTrak is not in your pharmacy. They can't see what you're physically getting. What they do see is what you're ordering on paper, what's going through or what's coming to you from your supplier. They see all that, but they can't validate it at the store, and that's where the pharmacies come in. There's different ways that pharmacies can account for the product that they receive. There's a number of different ways that they can do that. But what we've done with our system, our integration with InfiniTrak is we lessen that additional scanning piece. So ideally, we can
13:19 Speaker 03 When a pharmacy receives a product, they need to, the best way to do it is to scan it into their system. That way, it's all done electronically and we can see everything. And then, and then if Infinitrac sees something that's missing, they can alert the pharmacy that, hey, you know, you ordered this, but we didn't see that come in. What we've done is we built that into the workflow as well. So when a pharmacy is actually going through, through the, um, through their workflow process, they scan that bottle, that bottle is sent over to Infinitrac to continue to validate that this product was from this order with that new QR code that's all for, all products are to have.
13:59 Speaker 03 So the additional, um, the, the QR code that every product has now has not only the lot and expiration, it also has the G10 and the serial number. Remember, every product out there, every bottle has its own unique serial number. And then that is what's being, that's, that's part of the DSCSA law and why, uh, how to make it easier to track a product from the time it's manufactured to the time it hits the pharmacy and everyone in between. So it's kind of a big picture, overall view of, of, of what we're doing. But the, the integration that we at Primarex have created simplifies that process and minimizes the amount of extra work the pharmacy is going to need to do to be compliant.
14:44 Speaker 04 That's right. And Sam brought up a good point, um, that I didn't really focus on when I spoke before, but this law was rolled out in two phases. The first phase, what we call lot level tracking, where in all pharmacies, all dispensers, all, um, all wholesalers, et cetera, need to be compliant with a lot level tracking today before this deadline of the 27th. That lot level tracking requires you to be receiving this data today at a lot level, um, which is used with, um, an EDI transaction, the lot level, um.
15:21 Speaker 04 Tracking started in 2016 and everybody should be receiving that they need to have a SOP describing how they're complying with the law. And they need to be checking their, their, their trading partners licensing to make sure they're not working with bad actors. As we move into the second phase, we're going from lot level tracking to product level tracking. And that means we're gathering serial numbers for every single saleable unit in your pharmacy, which is an enormous amount of data. It required a different kind of data protocol, which we call EPSUS. And it's all, the EPSUS data protocol is also an interoperable protocol, which allows
16:02 Speaker 04 you to communicate back into the supply chain to do things like product verification. If you do get a product that may be suspect. And as we, you know, that's kind of a confusing description to pharmacists as, as they're doing all the heavy lifting for all the other compliance issues within their pharmacy. Often the question we got is, you're telling me you're gonna, we're gonna have to do this, this check-in process twice? We're gonna have to scan products twice? We're gonna have to make sure we were receiving this, this workflow receiving multiple times within our pharmacy? We're already overwhelmed.
16:43 Speaker 04 And this integration with, with micro merchant understands that pharmacy's present burden and actually makes it so that there's not additional workflow from what they were doing before, because they're, the way I understand it, but Sam, correct me, but they're using actions that have already happened in their workflow and integrating our platform with theirs with the data to make sure that the proper checks and balances are happening with the Drug Supply and Security Act data, so that they don't actually have added workflow to be compliant, but they get the full compliance package. And as Sam referenced, we put these real-time alerts to advise them directly if there's
17:26 Speaker 04 a conflict or a problem with the drug or a license. That way they, they, they live in their PRMRX platform. We, we exist behind the scenes. We don't add to their workflow, but we achieve full compliance and protect the patients as, as a result.
17:47 Speaker 03 Exactly, Mark. And to add to that, the
17:52 Speaker 03 the end, the double scanning is the key piece. So PrimeRx, we've done something unique that I don't know if anyone else does it. And that is the way we're taking that serial number or that scan in within workflow eliminates the need for a pharmacy to have to double scan or scan a product twice when they receive it. Once for their inventory, once for the InfiniTrak system. The integration helps to do that and it creates what I consider a double check on that product. So for pharmacies that do scan product in, PrimeRx is going to see that anyway and we can send that over to
18:33 Speaker 03 to the InfiniTrak system, but also when we double check it during workflow, that goes back to revalidate to InfiniTrak that the product is, in fact, what was ordered is what was received from that standpoint.
18:51 Speaker 04 Absolutely. It is a really, it's a very impressive, smooth system that PrimeRx customers are able to use. And like I said, get full compliance and not add to their workflow, which is a very important point for, I hear from pharmacists on a regular basis.
19:09 Speaker 03 Exactly. And so the fact that the alerts that you mentioned, Mark, that's unique because a pharmacist in order to check, or the pharmacy in order to check to make sure everything's correct, they'll have to go into their system or into the InfiniTrak portal to look for, oh, did this order come in? Okay, did this come in? Fine, what have you? It basically, the system alerts the pharmacy that, hey, you ordered this, but actually we haven't seen it, or we didn't see this, or it's not correct. We alert the pharmacy. So it's a call to action, basically letting the pharmacy know, hey, something's not right with that order, with that product. And then they can start investigating at that point.
19:49 Speaker 04 Absolutely. And the common refrain I would hear when we were first
19:55 Speaker 04 marketing the product was, oh, no, not another portal I have to cite it to pharmacists. You know, the many different portals that they have to use in order to do their daily business. So this integration really helps reduce that for the pharmacy. It's exciting, it's exciting for me. So.
20:16 Speaker 02 The simplicity and the assurance that I have a technology company, my pharmacy system that is tied into this, it really puts me at ease. If I was thinking of, if I was an owner, I don't want to think about so many of these things when I have employees, have the audits and I have things going on. And obviously my patients, my community is the most important thing. And now PrimerX and InfiniTrak bringing something to the table that just brings seamlessness to it. So this is good to hear.
20:50 Speaker 03 There's a lot of, I'm sorry, Mark, there's a lot of confusion out there, Todd, in what they need to be doing, what the pharmacy needs to do. And then when you hear about the delays, and Mark, you may want to touch on this, when you hear about the delays, they're like, oh, we don't have to do anything until another year or what have you. There's a new delay that affects a certain portion of the pharmacy. And you can explain that a little better. But remember, there are procedures that you need to be doing today. So there are aspects, the first phase is in place today. So Mark, go ahead.
21:27 Speaker 04 Yeah. So there is a term we call WES in the industry, which is an abbreviation for three categories of what we loosely call delays, which are really aren't delays. There's waivers, exemptions, and exceptions. But recently, there was an exemption letter sent out for pharmacies, which gave a delay for interoperability for pharmacies with 25 or less full-time pharmacists and pharm techs. This was a delay recognizing that the full
22:08 Speaker 04 data stream wasn't up and running. They weren't able to send all the serialized data yet. This happened about a couple of months ago. And that delay gave pharmacies the ability to wait a little bit of extra time to have the serialized part of the law fully compliant. However, the first phase that we talked about before, receiving the data. Authorizing your partners finding suspect product, reporting suspect product, still in full force. So it's a little bit confusing when we use the word delay because there wasn't really a delay of the law. It was just a
22:53 Speaker 04 exemption of some of the requirements as per serialization. Then we had just recently, last month, I'm sorry, not last month, this month, October 9th, a further exemption for all stakeholders in the supply chain that said that if you're eligible, that eligible for this exemption, you and you receive a product without full serialization, you will have an exemption. But the eligibility is what the key is there. The eligibility is that you're fully connected to your trading partners, receiving all of the data
23:34 Speaker 04 for all the compliance data and that you are making documented efforts to get serialized data from all your trading partners and/or if you're a manufacturer to send it, send that data. So that's a big, those are big eligibility items because it means you have to be on a system. You have to be compliant with at least a first phase today in order to get this exemption on some of the serialized product that, or some of the nonserialized product that will come through the supply chain. In this exemption, which I think is actually a really good exemption, except for the fact it's being interpreted as a delay, but I'll address that in a second.
24:17 Speaker 04 But this exemption is staggered. So manufacturers have until May to use this exemption. Wholesalers have until August of 2025 to use this exemption. And dispensers have until November 27th to use this exemption. So they staggered it, recognizing that in order to ensure serialized data is out there, manufacturers have to be doing it 100%. So their deadline with this exemption is in May. And then in order for a dispenser to further get the right serialized data, the wholesalers have to be fully 100% serialized. So theirs is in August and then we move into November for dispensers. But it's important to understand that it's really not a delay.
25:04 Speaker 04 The law is fully in place. And what these exemptions really say is this is what the intent of the FDA is on enforcement. They're going to give you some leeway on serialized data if you're not receiving it from your trading partners. As long as you're receiving data, you're making documented efforts to make sure you're receiving serialized data. Then you'll have, you have an exemption on that one part, which is really a product level exemption for those products that aren't serialized. It was, um, there was a lot of panic out there because we knew that some wholesalers or manufacturers are not going to be able to send
25:46 Speaker 04 all serialized data on the deadline that's coming up in about three weeks. Um, and we didn't know exactly how we're going to handle that. So this last exemption was, uh, was received very well by the entire industry, I believe. Uh, but it's, it's, um, it's important people understand that it doesn't mean you can't, don't have to do anything until next year. It doesn't mean you don't have to do anything until 2026. And it just narrows down the scope a little bit, gives you a little bit more runway. It allows the manufacturers and the wholesalers to, um, to refine their systems and get you the serialized data. And once this is done, it's going to be a great improvement for patient safety within the supply chain.
26:31 Speaker 04 That, uh, we should all be proud of.
26:34 Speaker 03 So just to kind of change, move, move a little, in a little different direction. I do want to address one, one area that is still an issue today, um, as it's been since, since the law was, was enacted. And that is pharmacies that don't understand why, um, they need to use a service, um, when they can do it themselves. Or the biggest misnomer is, well, my wholesalers got me covered. They have a portal, they're keeping track of all that data. That is exactly correct. That's a hundred percent correct. So if you're buying from, from, from your primary, they, they all have a portal where you can go in and see what you purchased.
27:14 Speaker 03 That's all they do. Now, keep in mind, if you're purchasing from multiple wholesalers, which everybody does, and you know, for the most part, then every one of your wholesalers need to provide you with that portal for you to have access to. So if you're auditing, now you've got to go to five or six different wholesalers. Some may have a portal. The bigger guys do, the smaller guys may not. So you're not going to, that data's not going to be at your, at your disposal as quickly. And the, Mark, what is it, 48 hours you're given to?
27:45 Speaker 04 Forty-eight hours you're given to produce data. So if an inspector comes in and asks you for a certain set of data, maybe of a date range, or an NDC level, or even a wholesaler level, you're given 48 hours to produce that data. If you have all that data in a bunch of other portals, and you need help to get that data out of the portals, which is going to be likely, then you may, you may not, probably will not make that 48-hour deadline. In addition to that, that, those portals give kind of a false sense of confidence that you're compliant using those portals. All those portals are really doing is providing
28:25 Speaker 04 a repository for that data. It's not checking the licenses. You need to be checking licenses. It is a responsibility of the dispenser to make sure everybody's license is good. You need to have documented that you did it. Now, you know, you, the response will be, oh, why would Cardinal's license not be good? Right? But you still need to be doing it. It's a requirement of the law. And then the, the second piece is identifying suspect product. So if what you're doing is receiving the data in the portal and it's saving there, you're comfortable doing that, you're not really viewing the data. Right? So you're
29:03 Speaker 04 not aware if the data is missing components, or you, you may not catch a suspect product that you're required to catch, investigate, and report, because that data is not in the portal in front of you. It is not in that, in that dashboard in front of you. So while you can do it with, with the, with the portals, and you can do some of these other tasks manually, like check licenses, it's well worth. The cost of a system to have it all in one dashboard. And furthermore, if it's integrated into your pharmacy management system, which you're you're already using and dependent on, then it makes the whole process much easier, much more automated.
29:45 Speaker 04 I also wanted to mention about that automate, we make great efforts to make sure this process is automated. But we don't just walk away from the customer after that. We have a very robust customer service and regulatory expert staff that's always on call, interacting with the customer to make sure that this process is easy for them. We we don't just give you the tools and leave you alone. We're there to help you on every step of the process.
30:15 Speaker 02 All right, so I'm going to kick things back to Sam, just as a shout out to listeners. For people, for pharmacy owners that are using PrimeRx, there's a less risk because you already have something that you can build in. And that's terrific. Can you give some advice to our to other pharmacy owners who might not be PrimeRx customers as to maybe how to make the assessment about their own system and maybe what's the what's the next phase for them to to have an environment that makes things this seamless?
30:56 Speaker 03 So for non-PrimeRx users, depending on, and a lot of it is what are their PMS vendor doing? Are they are they supporting DSCSA? Do they provide the tools? How how is that being done? One of the biggest issues that the pharmacies will have, it's been my experience with non-PrimeRx users is handling, you know, you've got to be prepared to handle the additional workflow that's going to be required for product intake. When you receive your product, you're not currently scanning that in into your system, then the challenge will be that that you're not
31:40 Speaker 03 You don't know if what you ordered is is in fact what you received. It could be just a simple lesson. The thing to keep in mind is having, you know, serial number. It's almost impossible to do it manually. You need scanning is and the law does not require you to scan, but it is the most efficient and accurate way to to to bring in product. To me, that's going to be the biggest, the biggest piece you've got to prepare for is the additional workload. And making sure that you have your your SOWs or SOP in places for, you know, and that's when an inspector comes in, that's one thing that the first thing they're going to ask for is, what's your standard operating procedure for suspect or legitimate products?
32:24 Speaker 03 What do you do when you receive something that's questionable? Where's your quarantine area? What, how are you handling it? Do you put it off to the side? You know, so those are things you've got to justify and need to have be prepared for. We, you know, through Infinity Track, of course, we do have all those pieces available. And they have them, but if you're not on, obviously for the non-prime RX, make sure you you have those those pieces in place. It's very important. You come in and when you, when you get inspected, when inspection takes place, it is being prepared to, the first thing is going to be, show me what you do. And then the next would be, okay, they'll take, they could take a product off the shelf and say, give me the serialized information, the tracking information for this product.
33:09 Speaker 03 So those are the type of things to to be prepared for on that. We're pushing to our customers that they that they need to be compliant by the end of this, by the 27th. For for those pharmacies that think that they're they're they're safe, make sure, you know, you understand the law and understand what you need to be doing. That, to me, that's the biggest piece.
33:31 Speaker 04 Yeah, and I'll say when you're comparing other options, making sure you have that data flow and it's continuous. What we've found is that sometimes the vendor's connection breaks. And if you're not paying attention to that data flow, then you may be in a position where you don't know that you're not receiving the data. And then if an inspector comes in and asks you for serialized or for compliance data for a certain item, which they may do, just pick it off the shelf, you may discover at that point, you don't have that, you don't have that data flow coming into your system. One of the things we do is we give you an alert if you're, if you're a Cardinal customer, then all of a sudden you're not getting any
34:15 Speaker 04 Cardinal transactions. We're going to give you an alert that says, you know, you haven't received a Cardinal transaction for this time period, which will give you an alert that maybe there's a problem with the data flow. And our system will detect it also. It's also important that there's an issue with, with, well, we, we talk about exceptions in, in, in the industry about with Drug Supply Chain Security Act. An exception can be you receive a product without data, or a data, or data without a product. So if you get a mispick from your wholesaler, where they put something in your tote that does not belong there, you didn't order, probably didn't pay for, that's what we call an exception.
35:00 Speaker 04 And if you're going to put that on your shelf, you need to make sure you have that data with that product. Now, if you're depending on a portal, you're not going to know you got it, you, you're not going to be aware of that mispick because you're not seeing that compliance data. It's important you're able to deal with these exceptions, and you have a partner that will alert you to the exceptions and help you solve that exception with the right kind of exception reporting. With the integration with Primer X, we have these real time alerts tell you if you have an exception, and then we process it with a report to make sure you're fully compliant. But um, there's a lot of little things out there that you need to pay attention to and understand the law to make sure you're
35:45 Speaker 04 fully compliant. So it's important to have a partner that will help educate you in that process also.
35:54 Speaker 02 Excellent. Excellent. Thank you both. Mark, this has been terrific to talk with you and catch up with the InfiniTrak team. Thank you for being part of this podcast episode. Sam, we have to meet up more often than maybe once or twice a year. I think the X conference I'm going to that we saw you at last year was Assembia. So maybe we'll actually find some time to talk there about how Primer X is in the specialty pharmacy market as well.
36:21 Speaker 03 I will see you there, Todd, for sure. I'll be there.
36:25 Speaker 02 Excellent. Hey, if you're a pharmacy owner, you're concerned with this. If you're a pharmacy technician that runs the compliance division of your pharmacy, do not fear. There's lots of guidance out there. Reach out to Primer X. Go to primerx.io or even take a look at the InfiniTrak site, which is in infinitrak.us. Once again, that's infinitrak.us. Mark, Sam, this has been special. Appreciate you sharing with us and our listeners.
36:55 Speaker 03 Thank you, Todd.
36:57 Speaker 04 Thank you very much.
Previous Welcoming the Answer Page to PPN | The Answer Page Podcast | Cannabis Pharmacy University Next Franchisee Success with Dana and Toby Porter | Happier at Home PRN Page updated November 15, 2026 · transcript and summary are machine-generated